Physician profile
Thomas P Orourke
NPI 1245292341
$613.27
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $95.55 · 2021: $68.14 · 2022: $165 · 2023: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $154.92 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.07 | 2019-2023 | |
| Myovant Sciences INC. | $59.24 | 2021-2022 | |
| Duchesnay USA Incorporated | $58.49 | 2019 | |
| Sumitomo Pharma America, INC. | $49.92 | 2023 | Myfembree |
| Exeltis, USA INC. | $49.58 | 2020-2023 | Slynd |
| Axonics, INC. | $39.22 | 2022 | |
| Sage Therapeutics, LLC | $23.41 | 2022 | |
| Therapeuticsmd, INC. | $16.67 | 2022 | |
| Abbvie INC. | $15.53 | 2020 | |
| Exact Sciences Corporation | $15.45 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $15.43 | 2019 | |
| Avanos Medical | $13.22 | 2020 | |
| Minerva Surgical, INC | $13.17 | 2022 | |
| Allergan, INC. | $12.51 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Orourke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.